Intellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases...
Read moreIntellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases...
Read moreAnnual Revenue
$51.4M
Intellia's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 26.1M. Over the last four quarters, Intellia's revenue has grown by 3.2%. Specifically, in Q3 2022's revenue was $13.3M; in Q2 2022, it was $14M; in Q1 2022, it was $11.3M; in Q4 2021, Intellia's revenue was $12.9M.